Pershing Square Capital
View Older Stories View More Recent Stories
-
Form SC 13D/A ALLERGAN INC Filed by: Pershing Square Capital Management, L.P.
-
Allergan (AGN) Responds to ISS and Glass Lewis Recommendations, Says Offer Still Grossly Inadequate,
-
Glass Lewis Backs Pershing Square's Call for Allergan (AGN) Special Meeting
-
Top 10 News for 7/28 - 8/1: FOMC Tapers Further, Rates Still Intact; Jobs Growth Elusive in July; Argentina Defaults. Again.
-
Valeant Pharmaceuticals (VRX), Pershing Call Allergan (AGN) Lawsuit Frivolous
-
Allergan (AGN) Files Complaint Against Valeant (VRX), Pershing Square; Alleges Violation of Securities Laws
-
Herbalife (HLF) Ticks Higher, Shorts Expand Positions into Q2 Report
-
Market Wrap: CPI Gains 0.3% in June; Another Ack-Attack on Herbalife; Apple Bruised on Q2 Phone Sales
-
Herbalife's (HLF) Squeeze Higher Continues Following Pershing Square Presentation
-
Herbalife (HLF) Comments on Pershing Square's Three-Hour Presentation; Says Ackman Over-Promised, Under-Delivered on Short Bet
-
Herbalife (HLF) Can Hit $300/sh in Next 5-10 Years, Says Chapman - CNBC
-
Herbalife (HLF) Goes Red-to-Green Early in Ackman Presentation
-
Herbalife (HLF) Down 1% as Pershing Square Presentation Set to Start
-
Herbalife (HLF) on Watch Ahead of Pershing Square Presentation
-
Herbalife (HLF) Peers Pressured Again as Ackman Plans Roasting (USNA) (NUS)
-
Unusual 11 Mid-Day Movers 07/21: (RGDO) (EXTR) (PLUG) Higher; (EZPW) (ITRI) (ICLD) (More...)
-
Herbalife (HLF) 'Freaked' Ahead of Presentation - Ackman
-
Herbalife (HLF) Lower Ahead of Tomorrow's Pershing Square Presentation
-
Pershing Square Updates Information on Herbalife (HLF) Nutrition Clubs Presentation
-
Herbalife (HLF) Responds to Continuing Attacks From Pershing Square
-
Streetinsider.com's Hot Lunchtime Reads 07/17: (EBAY) (ADTN) (BA) (HLF)
-
UPDATE: Pershing Square to reveal probe into Herbalife (HLF) on July 22nd
-
Herbalife (HLF) Slumps; Group of Members Travelling to DC in Support of Company
-
Allergan (AGN) CEO Pyott: We're Looking to Do Our Own Acquisitions (VRX) (SHPG)
-
Pershing Square Proposes Slate of Six Directors for Allergan (AGN) Board
-
Market Wrap: Private Payrolls Expand in June; Tyson Makes $8.55B Bid for Hillshire
-
Pershing Square Files Solicitation For Special Meeting of Allergan (AGN) Shareholders
-
Ackman's Pershing Square Gained 25% in H1 2014 (AGN)
-
Pershing Square Taps Top Global Bank in Effort to Bring Valeant (VRX) and Allergan (AGN) Together
-
Valeant Pharma (VRX) on Watch Following Pershing Square, Allergan (AGN) Suit Settlement
-
Pershing Square, Allergan (AGN) Settle 'Poison Pill' Suit
-
Valeant Pharma (VRX) CEO Says Allergan (AGN) Shareholders Support Meeting on Takeover
-
Shire plc (SHPG) Hires Goldman as Adviser - NYT
-
Allergan (AGN) Rejects Unsolicited Exchange Offer from Valeant (VRX)
-
Pershing's Lawsuit Against Alergan (AGN) Fast-Tracked - WSJ
-
Valeant Pharma (VRX) Announces Commencement of Allergan (AGN) Exchange Offer
-
Pershing Square Files Lawsuit Against Allergan (AGN) to Confirm Special Meeting Will Not Trigger Poison Pill
-
Market Wrap: BE Aerospace Plans Split; Valeant, Pershing Square Rejected; New AIG Boss
-
Notable Mergers and Acquisitions of the Day 06/10: (AGN)/(VRX) (BEAV) (PPL) (CLSN)
-
Allergan (AGN) Rejects Revised Offer from Pershing Square, Valeant (VRX)
-
Herbalife (HLF) on Watch as Ackman Sees 'Arrests'
-
Allergan, Inc. (AGN) Holder Pershing Square Files to Withdraw Prelim. Proxy
-
Pershing Square Comments on BurnLounge Verdict; Draws Similarities to Herbalife (HLF)
-
Market Wrap: Apple Debuts New Software, Apps; Broadcom Looks to Exit BaseBand Business
-
Notable 52-Week Highs and Lows of the Day 06/02: (AGN) (LNG) (DAL) High; (NEON) (BEBE) (WLT) Low
-
Valeant Pharmaceuticals (VRX) PT Raised to $209 at Cantor Fitzgerald
-
Allergan, Inc. (AGN) Responds Pershing Square's Proxy Filing
-
Valeant Pharmaceuticals (VRX), Pershing Square Revise Offer for Allergan; Now $72/Share Cash, 0.82 of Valeant Stock
-
Life Time Fitness (LTM) Could Consider REIT With Activist Breathing Down its Neck - Piper Jaffray
-
Pershing Square Says Allergan (AGN) Needs Independent Counsel

